"Propylamines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Derivatives of propylamine (the structural formula NH2CH2CH2CH3).
Descriptor ID |
D011437
|
MeSH Number(s) |
D02.092.831
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Propylamines".
Below are MeSH descriptors whose meaning is more specific than "Propylamines".
This graph shows the total number of publications written about "Propylamines" by people in this website by year, and whether "Propylamines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2010 | 1 | 0 | 1 |
2011 | 2 | 0 | 2 |
2013 | 1 | 0 | 1 |
2017 | 0 | 1 | 1 |
2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Propylamines" by people in Profiles.
-
Zhou W, Feng M, Valadez A, Li X. One-Step Surface Modification to Graft DNA Codes on Paper: The Method, Mechanism, and Its Application. Anal Chem. 2020 05 19; 92(10):7045-7053.
-
Tasnim N, Kumar A, Joddar B. Attenuation of the in vitro neurotoxicity of 316L SS by graphene oxide surface coating. Mater Sci Eng C Mater Biol Appl. 2017 Apr 01; 73:788-797.
-
Felhofer JL, Scida K, Penick M, Willis PA, Garcia CD. Simultaneous solid phase extraction and derivatization of aliphatic primary amines prior to separation and UV-absorbance detection. Talanta. 2013 Oct 15; 115:688-93.
-
Ball MP, Warren KR, Feldman S, McMahon RP, Kelly DL, Buchanan RW. Placebo-controlled trial of atomoxetine for weight reduction in people with schizophrenia treated with clozapine or olanzapine. Clin Schizophr Relat Psychoses. 2011 Apr; 5(1):17-25.
-
Waxmonsky JG, Waschbusch DA, Akinnusi O, Pelham WE. A comparison of atomoxetine administered as once versus twice daily dosing on the school and home functioning of children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2011 Feb; 21(1):21-32.
-
Waxmonsky JG, Waschbusch DA, Pelham WE, Draganac-Cardona L, Rotella B, Ryan L. Effects of atomoxetine with and without behavior therapy on the school and home functioning of children with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2010 Nov; 71(11):1535-51.
-
Tamayo JM, Pumariega A, Rothe EM, Kelsey D, Allen AJ, V?lez-Borr?s J, Williams D, Anderson SG, Durell TM. Latino versus Caucasian response to atomoxetine in attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2008 Feb; 18(1):44-53.